The IPO Cycle: Why the Market Has Reopened but Selectively

The Window Is Open. That Is Not the Whole Story.
The Sloane Team
April 9, 2026
Strategy

The IPO market has returned. Deal activity is up, investor appetite has stabilized, and the conversation inside boardrooms has shifted from when the market will come back to whether a company is ready for it. But volume is not the right metric to watch. The composition of deals is.

The companies getting through in this cycle share a specific profile. They are profitable or credibly near it. Their management teams have operated through difficult environments, not just favorable ones. Their equity stories hold up under institutional scrutiny. The window is open, but it is functioning as a filter, and most companies looking at it from the outside do not yet meet the conditions on the other side.

Understanding why requires looking past the recovery narrative.

What Actually Changed

The drivers behind this recovery are structural, not cyclical. What happened between 2022 and 2025 was a fundamental reset in how institutional capital prices risk, and that reset is now embedded in how deals get done.

The rate cycle that began in 2022 forced institutional allocators to reprice their entire portfolios, including private equity positions and pre-IPO holdings. When rates stabilized, the repricing had already occurred. The return of investor appetite came with new floor conditions attached, and those conditions have not relaxed.  

The 2021 IPO vintage reinforced them. A significant cohort of companies that listed at peak valuations traded down 60 to 80 percent within 18 months of their offerings. SPAC IPOs of unprofitable companies listed on peak multiples based on hockey-stick projections. Institutional memory on that experience is long. Underwriters remember which deals broke and why. That cohort effectively closed the door on speculative listings for this cycle.

What Institutional Investors Are Now Requiring

The bar has moved in specific ways. Investors want to see the business performing at scale before they price it as though it will.

Long gone is the “growth at all costs” mantra. Now, unit economics and other profitability metrics need to be demonstrated at or near the time of filing. Management credibility is under a different level of scrutiny. CFOs are being evaluated on whether they have led a finance function through a contraction, not only a period of growth. Investors want evidence that leadership has the operating discipline to manage through a difficult environment, because they are pricing in the likelihood that one will come.

Equity stories are being stress-tested during book-building, not after the transaction closes. Investors are pressing hard questions in the room, and the order book reflects how those conversations go. Companies that cannot defend their narrative under pressure see it directly in their pricing outcomes.

Valuation must be anchored to public market comparables. The gap between a company's last private round mark and what the public market will actually pay has ended several high-profile processes before they reached the finish line. Private round history is not a reference point that institutional investors are willing to work backward from. ‘Down-rounds’ are to be expected.  

What This Means for Issuers and Sponsors

Timing is no longer the primary variable. In prior cycles, management teams and sponsors optimized around market windows. In this cycle, readiness determines access. Companies that filed when conditions appeared favorable but had not done the necessary preparation have paid for it in valuation haircuts and broken transactions.

The companies completing successful listings in this cycle began preparing 18 to 24 months before filing. That preparation encompasses financial reporting infrastructure, governance, investor messaging, analyst and institutional investor relationships. It is not work that begins when the underwriter is retained.

For PE sponsors, the portfolio companies achieving successful IPO outcomes are those where the sponsor built public-company readiness into the ownership thesis from the outset, not as a late-stage response to favorable market conditions.

Narrative and institutional credibility have moved from secondary considerations to hard execution variables. How a company tells its story, who delivers it, and how it performs under institutional scrutiny now directly affects where the deal prices and how it trades in the period that follows.

The Market Is Functioning as It Should

The IPO market is not broken. It is rewarding preparation and penalizing shortcuts, which is precisely how a mature capital market is designed to work. The opportunity in this cycle is real, but it belongs to the companies and sponsors who treat the public markets as the next chapter they built toward rather than a liquidity event they timed.

The balance of this series examines what that preparation looks like in practice, from governance and reporting infrastructure to equity narrative construction and institutional investor engagement. At Sloane, that work sits at the center of what we do for companies approaching the public markets and the sponsors backing them.

For guidance on navigating these shifts, contact Sloane Capital Markets & Strategic Advisory.

Zack Mukewa is Principal and head of Capital Markets & Strategic Advisory, guiding companies through transformative strategies.

Jared Pollack a Senior Vice President advising on investor relations for public companies and go-public strategies.

Interested in learning more about the connection between disclosures and reputation?

Get in Touch